Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$67.36 - $77.59 $740 - $853
-11 Reduced 0.11%
10,000 $733,000
Q4 2023

Feb 13, 2024

SELL
$64.27 - $69.9 $19,281 - $20,970
-300 Reduced 2.91%
10,011 $696,000
Q3 2023

Nov 13, 2023

BUY
$61.9 - $72.77 $637,570 - $749,531
10,300 Added 93636.36%
10,311 $689,000
Q1 2023

May 08, 2023

BUY
$51.63 - $56.93 $567 - $626
11 New
11 $1,000
Q1 2021

May 13, 2021

SELL
$57.98 - $73.08 $2.56 Million - $3.23 Million
-44,200 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$62.61 - $71.29 $68,871 - $78,419
-1,100 Reduced 2.43%
44,200 $3.15 Million
Q3 2020

Nov 09, 2020

SELL
$51.39 - $72.41 $1.03 Million - $1.45 Million
-20,000 Reduced 30.63%
45,300 $3.15 Million
Q2 2020

Aug 12, 2020

SELL
$39.55 - $54.65 $435,049 - $601,150
-11,000 Reduced 14.42%
65,300 $3.46 Million
Q1 2020

May 04, 2020

SELL
$34.75 - $45.85 $417,000 - $550,200
-12,000 Reduced 13.59%
76,300 $3.08 Million
Q4 2019

Feb 12, 2020

SELL
$36.66 - $41.78 $498,575 - $568,208
-13,600 Reduced 13.35%
88,300 $3.58 Million
Q2 2019

Aug 16, 2019

SELL
$36.05 - $42.76 $129,779 - $153,936
-3,600 Reduced 3.41%
101,900 $3.82 Million
Q1 2019

May 13, 2019

SELL
$35.77 - $40.57 $1.57 Million - $1.78 Million
-43,800 Reduced 29.34%
105,500 $4.27 Million
Q4 2018

Feb 05, 2019

BUY
$31.89 - $38.44 $1.73 Million - $2.08 Million
54,100 Added 56.83%
149,300 $5.63 Million
Q3 2018

Nov 07, 2018

BUY
$29.25 - $36.73 $2.78 Million - $3.5 Million
95,200 New
95,200 $3.29 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.29B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.